Nephro-Urology Monthly

Published by: Kowsar

Relationship Between Clinical and Urodynamic Findings in HTLV-1-Infected Patients with HAM/TSP

Mahmoud Tavakkoli 1 , Maliheh Keshvari Shirvan 1 , Alireza Ghoreifi Nezhadian 1 , Maryam Salehi 2 , Hossein Keramati 1 , Amin Mirsani 1 and Salman Soltani 1 , *
Authors Information
1 Kidney Transplantation Complications Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2 Research Center for Patient Safety, Mashhad University of Medical Sciences, Mashhad, Iran
Article information
  • Nephro-Urology Monthly: 11 (2); e90198
  • Published Online: April 14, 2019
  • Article Type: Research Article
  • Received: February 3, 2019
  • Accepted: March 21, 2019
  • DOI: 10.5812/numonthly.90198

To Cite: Tavakkoli M, Keshvari Shirvan M, Ghoreifi Nezhadian A, Salehi M, Keramati H, et al. Relationship Between Clinical and Urodynamic Findings in HTLV-1-Infected Patients with HAM/TSP, Nephro-Urol Mon. Online ahead of Print ; 11(2):e90198. doi: 10.5812/numonthly.90198.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J. 2011;13(6):424-7. [PubMed: 22737506]. [PubMed Central: PMC3371930].
  • 2. Shoeibi A, Etemadi M, Moghaddam Ahmadi A, Amini M, Boostani R. "HTLV-I infection" twenty-year research in Neurology Department of Mashhad University of Medical Sciences. Iran J Basic Med Sci. 2013;16(3):202-7. [PubMed: 24470862]. [PubMed Central: PMC3881242].
  • 3. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172-6. doi: 10.1016/j.jcv.2011.07.004. [PubMed: 21840754].
  • 4. Araujo AQ, Leite AC, Lima MA, Silva MT. HTLV-1 and neurological conditions: When to suspect and when to order a diagnostic test for HTLV-1 infection? Arq Neuropsiquiatr. 2009;67(1):132-8. [PubMed: 19330234].
  • 5. Grindstaff P, Gruener G. The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes. Semin Neurol. 2005;25(3):315-27. doi: 10.1055/s-2005-917668. [PubMed: 16170744].
  • 6. Cooper SA, van der Loeff MS, Taylor GP. The neurology of HTLV-1 infection. Pract Neurol. 2009;9(1):16-26. doi: 10.1136/jnnp.2008.167155. [PubMed: 19151234].
  • 7. Poetker SK, Porto AF, Giozza SP, Muniz AL, Caskey MF, Carvalho EM, et al. Clinical manifestations in individuals with recent diagnosis of HTLV type I infection. J Clin Virol. 2011;51(1):54-8. doi: 10.1016/j.jcv.2011.02.004. [PubMed: 21388871]. [PubMed Central: PMC3074002].
  • 8. Oliveira P, Castro NM, Carvalho EM. Urinary and sexual manifestations of patients infected by HTLV-I. Clinics (Sao Paulo). 2007;62(2):191-6. [PubMed: 17505705].
  • 9. Shublaq M, Orsini M, Puccioni-Sohler M. Implications of HAM/TSP functional incapacity in the quality of life. Arq Neuropsiquiatr. 2011;69(2A):208-11. [PubMed: 21537562].
  • 10. Gascon MRP, Mellao MA, Mello SH, Negrao RM, Casseb J, Oliveira ACP. The impact of urinary incontinence on the quality of life and on the sexuality of patients with HAM/TSP. Braz J Infect Dis. 2018;22(4):288-93. doi: 10.1016/j.bjid.2018.07.003. [PubMed: 30145198].
  • 11. Castro NM, Freitas DM, Rodrigues W Jr, Muniz A, Oliveira P, Carvalho EM. Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals. Int Braz J Urol. 2007;33(2):238-44. discussion 244-5. [PubMed: 17488545].
  • 12. Costa DT, Santos AL, Castro NM, Siqueira IC, Carvalho Filho EM, Glesby MJ. Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome. Arq Neuropsiquiatr. 2012;70(4):252-6. [PubMed: 22510736]. [PubMed Central: PMC3627489].
  • 13. Boostani R, Mellat Ardakani A, Ashrafi H. Khorasan disease: Prevalence of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in West Azarbaijan from 2004 to 2007. Iran Red Crescent Med J. 2011;13(6):428-30. [PubMed: 22737507]. [PubMed Central: PMC3371933].
  • 14. Sakiyama H, Nishi K, Kikukawa H, Ueda S. [Urinary disturbance due to HTLV-1 associated myelopathy]. Nihon Hinyokika Gakkai Zasshi. 1992;83(12):2058-61. Japanese. [PubMed: 1474715].
  • 15. Walton GW, Kaplan SA. Urinary dysfunction in tropical spastic paraparesis: Preliminary urodynamic survey. J Urol. 1993;150(3):930-2. [PubMed: 8345613].
  • 16. Rocha PN, Rehem AP, Santana JF, Castro N, Muniz AL, Salgado K, et al. The cause of urinary symptoms among human T lymphotropic virus type I (HLTV-I) infected patients: A cross sectional study. BMC Infect Dis. 2007;7:15. doi: 10.1186/1471-2334-7-15. [PubMed: 17352816]. [PubMed Central: PMC1828158].
  • 17. Lima CL, Rabolini G, Menna-Barreto M, Dos Santos EB, Koff WJ. Urodynamic alterations in patients with HTLV-1 infection. Int Braz J Urol. 2002;28(5):452-6. discussion 456-7. [PubMed: 15748372].
  • 18. Mori K, Noguchi M, Matsuo M, Nomata K, Nakamura T, Kanetake H. Natural course of voiding function in patients with human T-cell lymphotrophic virus type 1-associated myelopathy. J Neurol Sci. 2004;217(1):3-6. [PubMed: 14675601].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments